Lyophilization of biologics: innovations, challenges, and future directions in stabilizing next-generation therapeutics

Khatoon, S, Haque, S, Saleem, I ORCID: 0000-0003-2382-6668 and Khan, FH (2026) Lyophilization of biologics: innovations, challenges, and future directions in stabilizing next-generation therapeutics. Critical Reviews in Biotechnology. ISSN 0738-8551

Preview	Text Figure and table.pdf - Supplemental Material Available under License Creative Commons Attribution. Download (766kB) | Preview
Preview	Text Lyophilization of biologics; innovations, challenges, and future directions in stabilizing next-generation therapeutics.pdf - Accepted Version Available under License Creative Commons Attribution. Download (661kB) | Preview

Abstract

Biologics, such as monoclonal antibodies, therapeutic proteins, gene therapies, and vaccines, are revolutionizing treatments for cancer, autoimmune disorders, and infectious diseases. However, their inherent sensitivity to environmental factors like heat and moisture necessitates advanced stabilization techniques. Lyophilization, or freeze-drying, has emerged as a critical method to preserve biologics by removing water through sublimation, resulting in a stable, dry powder. This review examines recent advancements in lyophilization, including the integration of Quality by Design (QbD) and Process Analytical Techniques (PAT), which enhance process optimization and product consistency. Regulatory frameworks from the FDA and EMA, coupled with advanced analytical methods, ensure the safety and efficacy of lyophilized biologics. The review also explores emerging technologies and innovations poised to address current challenges, such as scalability, cost-efficiency, and long-term stability. By synthesizing scientific, technological, and regulatory perspectives, this article provides a comprehensive overview of lyophilization's role in biopharmaceutical development and its future potential to meet the growing demands of biologic therapeutics.

Item Type:	Article
Uncontrolled Keywords:	Biologics; lyophilization; stability; efficacy; formulation; process optimization; regulatory compliance; advanced technologies; challenges; innovations; Biologics; advanced technologies; challenges; efficacy; formulation; innovations; lyophilization; process optimization; regulatory compliance; stability; 3206 Medical Biotechnology; 32 Biomedical and Clinical Sciences; Cancer; Biotechnology; 3 Good Health and Well Being; 06 Biological Sciences; 10 Technology; Biotechnology; 3001 Agricultural biotechnology; 3106 Industrial biotechnology; 3206 Medical biotechnology
Subjects:	R Medicine > RM Therapeutics. Pharmacology
Divisions:	Pharmacy and Biomolecular Sciences
Publisher:	Taylor and Francis
Date of acceptance:	4 February 2026
Date of first compliant Open Access:	19 May 2026
Date Deposited:	18 May 2026 12:34
Last Modified:	19 May 2026 00:50
DOI or ID number:	10.1080/07388551.2026.2652316
URI:	https://researchonline.ljmu.ac.uk/id/eprint/28584

View Item